Şunu aradınız:: koncentracijah (Slovence - İngilizce)

koncentracijah klaritromicina v
changes in clarithromycin

n=114 koncentracijah hiv- 1
plasma hiv-1 rna at

na trgu je v raznih koncentracijah.
sulphuric acid is commercially available in varying concentrations.

preskus pri nizkih koncentracijah (μg/l)
test at low (μg/l) concentration range

koncentracijah hiv- 1 rna v tednih 12- 20
week s 12-20

v koncentracijah, ki ne presegajo 25 % v proizvodu
in concentrations < 25 % in the product

preglednice s podatki o nazivnih in dejanskih koncentracijah,
tabulation of chamber nominal and actual concentration data;

raztopine te snovi so optično neaktivne v vseh koncentracijah
solutions of this substance are optically inactive in all concentrations

nekatere snovi lahko pri majhnih koncentracijah vzpodbujajo rast.
some substances can stimulate the growth at low concentrations.

so poročali o zmanjšanih serumskih koncentracijah estradiola in progesterona.
decreased serum estradiol and progesterone concentrations have been lon reported in women treated with human leukocyte interferon.

v koncentracijah, ki ne presegajo 25 % v proizvodu [8]
in concentrations < 25 % in the product [8]

dasatinib pri subnanomolarnih koncentracijah zavira tudi kinaze iz družine src.
additionally, dasatinib inhibits src family kinases at subnanomolar concentrations.

klinični pomen teh sprememb v koncentracijah klaritromicina v plazmi ni znan.
the clinical significance of these changes in clarithromycin plasma levels is not known.

hmf je naravna sestavina, vendar običajno predstavljena v nizkih koncentracijah.
the daily intake of hmf may underlie high variations due to individual consumption-patterns.

(a) okoliških koncentracijah in usedanju oksidiranih žveplenih spojin; in
(a) ambient concentrations and deposition of oxidised sulphur compounds; and

16o zvišanih plazemskih koncentracijah prolaktina so poročali pri 47,4 % mladostnikov.
16 elevated plasma prolactin levels were reported in 47.4 % of adolescent patients.

talidomid je prisoten v spermi moških bolnikov v podobnih koncentracijah kot v plazmi.
thalidomide is present in the semen of male patients at levels similar to plasma concentrations.

hidrazin (cas 302-01-2) v koncentracijah 70 % ali več;
hydrazine (cas 302-01-2) in concentrations of 70 % or more;

informacije o koncentracijah tržnega ali kreditnega tveganja v okviru prevzetega zmanjševanja kreditnega tveganja;
information about market or credit risk concentrations within the credit mitigation taken;

informacije o koncentracijah tržnega ali kreditnega tveganja v okviru prevzetega zmanjševanja kreditnega tveganja;
information about market or credit risk concentrations within the credit mitigation taken;